Rivus Pharmaceuticals, Inc.

Rivus Pharma is a biopharmaceutical company based in Charlottesville, Virginia, with approximately 11 employees. The company is developing a new class of investigational medicines called controlled metabolic accelerators (CMAs) to address cardio-metabolic diseases, including obesity and associated conditions, by leveraging the natural process of mitochondrial uncoupling.